Copyright
©2010 Baishideng.
World J Gastroenterol. Apr 28, 2010; 16(16): 2017-2022
Published online Apr 28, 2010. doi: 10.3748/wjg.v16.i16.2017
Published online Apr 28, 2010. doi: 10.3748/wjg.v16.i16.2017
Table 1 Clinical features of the two groups of patients at examination n (%)
| Upper endoscopy finding | Total | P-value | ||
| Gastric ulcers | Duodenal ulcers | |||
| Case numbers (prevalence) | 254 (56.6) | 194 (43.4) | 448 (100) | |
| Age (yr) | 60.44 ± 15.27 | 51.99 ± 16.24 | 0.0011 | |
| Gender | ||||
| Male | 142 (55.8) | 110 (56.7) | 252 (56.2) | 0.8662 |
| Female | 112 (44.1) | 84 (43.3) | 196 (43.8) | |
| H. pylori | ||||
| Positive | 110 (43.3) | 121 (62.4) | 231 (56.7) | 0.0012 |
| Negative | 144 (56.7) | 73 (37.6) | 217 (43.3) | |
| Smoking | ||||
| Yes | 36 (14.2) | 31 (16.0) | 67 (15.8) | 0.5952 |
| No | 218 (85.8) | 163 (84.0) | 381 (86.0) | |
| Alcohol | ||||
| Yes | 21 (8.3) | 22 (11.3) | 43 (9.6) | 0.2742 |
| No | 233 (91.7) | 172 (88.7) | 405 (90.4) | |
| Co-medications | ||||
| Nil | 218 (85.8) | 187 (96.4) | 405 (90.4) | 0.0012 |
| Aspirin | 19 (7.5) | 3 (1.5) | 22 (4.9) | |
| NSAIDs | 17 (6.7) | 4 (2.1) | 21 (4.7) | |
Table 2 The impact of therapeutic efficacy according to H. pylori infection and ulcer location of patients n (%)
| Therapeutic efficacy | Total | P-value | ||
| Ulcer healed | Ulcer unhealed | |||
| H. pylori | ||||
| GU | ||||
| Positive infections | 77 (70.6) | 32 (29.4) | 109 | 0.661 |
| Negative infections | 99 (68.3) | 46 (31.7) | 145 | |
| DU | ||||
| Positive infections | 87 (71.9) | 34 (28.1) | 121 | 0.505 |
| Negative infections | 55 (75.3) | 18 (24.7) | 73 | |
| Medications | ||||
| GU | ||||
| Treat with PPI | 131 (79.4) | 34 (20.6) | 165 | 0.007 |
| Treat with H2RA | 56 (62.9) | 33 (37.1) | 89 | |
| DU | ||||
| Treat with PPI | 115 (78.2) | 32 (21.8) | 147 | 0.430 |
| Treat with H2RA | 34 (72.3) | 13 (27.7) | 47 | |
Table 3 The impact of therapeutic efficacy according to co-medications and ulcer location of patients n (%)
| Co-medications | Therapeutic efficacy | Total | P-value | |
| Ulcer healed | Ulcer unhealed | |||
| None | ||||
| Positive H. pylori infection | 159 (75.7) | 51 (24.3) | 210 | 0.370a |
| Negative H. pylori infection | 140 (71.8) | 55 (28.2) | 195 | |
| ASP | ||||
| Positive H. pylori infection | 8 (80) | 2 (20) | 10 | 0.195b |
| Negative H. pylori infection | 12 (100) | 0 | 12 | |
| NSAID | ||||
| Positive H. pylori infection | 6 (60) | 4 (40) | 10 | 0.035b |
| Negative H. pylori infection | 11 (100) | 0 | 11 | |
- Citation: Lee SW, Chang CS, Lee TY, Yeh HZ, Tung CF, Peng YC. Risk factors and therapeutic response in Chinese patients with peptic ulcer disease. World J Gastroenterol 2010; 16(16): 2017-2022
- URL: https://www.wjgnet.com/1007-9327/full/v16/i16/2017.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i16.2017
